Advertisement
Canada markets closed
  • S&P/TSX

    22,465.37
    +165.57 (+0.74%)
     
  • S&P 500

    5,303.27
    +6.17 (+0.12%)
     
  • DOW

    40,003.59
    +134.19 (+0.34%)
     
  • CAD/USD

    0.7345
    -0.0000 (-0.00%)
     
  • CRUDE OIL

    80.00
    -0.06 (-0.07%)
     
  • Bitcoin CAD

    90,164.52
    -1,092.63 (-1.20%)
     
  • CMC Crypto 200

    1,354.52
    -19.32 (-1.41%)
     
  • GOLD FUTURES

    2,419.80
    +2.40 (+0.10%)
     
  • RUSSELL 2000

    2,095.72
    -0.53 (-0.03%)
     
  • 10-Yr Bond

    4.4200
    +0.0430 (+0.98%)
     
  • NASDAQ

    16,685.97
    -12.33 (-0.07%)
     
  • VOLATILITY

    11.99
    -0.43 (-3.46%)
     
  • FTSE

    8,420.26
    -18.39 (-0.22%)
     
  • NIKKEI 225

    38,787.38
    -132.92 (-0.34%)
     
  • CAD/EUR

    0.6754
    -0.0002 (-0.03%)
     

Teva Stock Powers Ahead as Schizophrenia News Offsets Mixed Earnings

Teva Stock Powers Ahead as Schizophrenia News Offsets Mixed Earnings

Shares of Teva Pharmaceutical Industries were climbing yet again on Wednesday, after the company announced positive results in a trial of a schizophrenia medicine. Its quarterly results, also disclosed early Wednesday, were mixed. Revenue was $3.8 billion for the quarter, slightly better than the FactSet consensus estimate of $3.7 billion, while non-GAAP diluted earnings were 48 cents a share.